Your browser doesn't support javascript.
loading
Cancer Antigen 125 Expression Enhances the Gemcitabine/Cisplatin-Resistant Tumor Microenvironment in Bladder Cancer.
Yamashita, Takahisa; Higashi, Morihiro; Sugiyama, Hironori; Morozumi, Makoto; Momose, Shuji; Tamaru, Jun-Ichi.
Afiliação
  • Yamashita T; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Higashi M; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan. Electronic address: mhigashi@saitama-med.ac.jp.
  • Sugiyama H; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Morozumi M; Department of Urology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Momose S; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Tamaru JI; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Am J Pathol ; 193(3): 350-361, 2023 03.
Article em En | MEDLINE | ID: mdl-36586479
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cisplatino / Antígeno Ca-125 / Resistencia a Medicamentos Antineoplásicos / Microambiente Tumoral / Gencitabina Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Cisplatino / Antígeno Ca-125 / Resistencia a Medicamentos Antineoplásicos / Microambiente Tumoral / Gencitabina Idioma: En Ano de publicação: 2023 Tipo de documento: Article